MadeAi received a Gold Stevie® Award for its new AI-assisted Risk of Bias feature.

Public source

Publisher name

Public post

The September edition of Life Sciences Evidence with AI is here! 🔬🤖 This month, we are celebrating two major wins, introducing MadeAi’s new AI-assisted Risk of Bias fe…

Log in to read the full post

Company

MadeAi

Accelerating evidence synthesis with AI you can trust

Industry
Software Development
Location
Cambridge, US
Company size
11–50 employees

About MadeAi

MadeAi™, developed by CapeStart, is an AI platform that streamlines life sciences evidence synthesis workflows. Its flagship solution, MadeAi-LR, accelerates literature reviews by up to 60% while maintaining over 90% accuracy. MadeAi enables additional evidence synthesis workflows including GVDs, MIRs, CERs, and JCA assistance, among others. The platform combines advanced machine learning with human validation to ensure FDA and EMA compliance. MadeAi is headquartered in Cambridge, Massachusetts and supported by CapeStart’s global team of 600+ professionals.

See more

Latest activity

9 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.